ACT-1016-0707 free base · Synonyms: LPA1 receptor antagonist 2

ACT-1016-0707 is an orally active and selective LPA1 receptor antagonist.

For research use only. Not for human or veterinary use.

Target LPL Receptor

Research area Inflammation/Immunology

Purity >98% Stock Inquire

Data Sheet SDS COA

ACT-1016-0707 structure

CAS No.: 2569467-78-1

Download structure (.mol)

Pack sizes & pricing

Size	Price	SKU	Stock
25 mg	USD 480.00	BP-01449-100mg	In stock	Get quote
50 mg	USD 760.00	BP-01449-250mg	In stock	Get quote
100 mg	USD 1,200.00	BP-01449-500mg	In stock	Get quote
250 mg	USD 2,420.00	BP-01449-1g	In stock	Get quote
500 mg	USD 3,800.00	BP-01449-5g	In stock	Get quote

Need another size or custom synthesis? Request a quote.

Description

ACT-1016-0707 (Compound 49) is an orally active and selective LPA1 receptor antagonist. ACT-1016-0707 can be used for the research of fibrotic diseases .

Identifiers

SMILES: O=C(C1(C2=CC=CC=C2C(C)C)CN(S(=O)(N)=O)C1)NC3=C(OC)C=C(Cl)N=C3
InChIKey: UHFBJBPMIVQTBG-UHFFFAOYSA-N

Specifications

MW (average): 438.9280
Formula: C₁₉H₂₃ClN₄O₄S
CAS No.: 2569467-78-1
Physical state: Solid
Color: white to off-white
Shipping: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage: Powder 4℃ 2 year; In solvent -20℃ 1 month;

Solubility

soluble in DMSO

Documents

References

[1]. Lescop C, et al. Discovery of the Novel, Orally Active, and Selective LPA1 Receptor Antagonist ACT-1016-0707 as a Preclinical Candidate for the Treatment of Fibrotic Diseases. J Med Chem. 2024 Feb 22;67(4):2397-2424.

Same research area

Search Inflammation/Immunology